Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

SHA:600332 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	41,272	44,550	46,355	52,103	44,644	55,293
Market Cap Growth	-3.28%	-3.89%	-11.03%	16.71%	-19.26%	-0.72%
Enterprise Value	39,585	38,768	38,568	41,153	36,537	48,953
Last Close Price	26.75	27.51	28.02	31.46	26.42	31.63
PE Ratio	12.06	10.98	11.69	14.01	15.31	17.34
PS Ratio	0.62	0.59	0.65	0.75	0.72	0.85
PB Ratio	1.24	1.21	1.38	1.66	1.58	2.13
P/TBV Ratio	1.45	1.43	1.62	2.03	1.95	2.65
P/FCF Ratio	40.43	18.00	8.26	11.79	-	21.08
P/OCF Ratio	19.26	10.86	6.62	9.18	76.29	11.01
EV/Sales Ratio	0.50	0.51	0.54	0.60	0.59	0.75
EV/EBITDA Ratio	7.88	7.51	7.71	9.37	10.70	12.55
EV/EBIT Ratio	9.79	8.52	8.60	10.37	12.07	13.91
EV/FCF Ratio	33.91	15.66	6.87	9.31	-	18.67
Debt / Equity Ratio	0.37	0.33	0.36	0.32	0.34	0.26
Debt / EBITDA Ratio	2.88	2.20	2.30	2.14	2.60	1.62
Debt / FCF Ratio	12.00	4.83	2.14	2.25	-	2.54
Asset Turnover	0.99	0.99	1.01	1.10	1.06	1.20
Inventory Turnover	6.04	5.53	5.45	5.53	5.33	5.64
Quick Ratio	1.09	1.17	1.20	1.27	1.23	1.20
Current Ratio	1.46	1.55	1.53	1.64	1.62	1.57
Return on Equity (ROE)	9.73%	12.11%	13.09%	13.33%	11.41%	14.01%
Return on Assets (ROA)	3.18%	3.71%	3.98%	3.94%	3.24%	4.06%
Return on Capital (ROIC)	4.85%	6.03%	6.45%	6.28%	5.37%	7.09%
Return on Capital Employed (ROCE)	9.09%	10.74%	12.04%	11.72%	9.92%	12.79%
Earnings Yield	8.29%	9.10%	8.56%	7.14%	6.53%	5.77%
FCF Yield	2.83%	5.56%	12.11%	8.48%	-0.65%	4.74%
Dividend Yield	4.30%	2.72%	2.61%	2.18%	2.04%	1.86%
Payout Ratio	46.58%	39.09%	37.58%	34.03%	44.25%	32.79%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-
Total Shareholder Return	4.30%	2.72%	2.61%	2.18%	2.04%	1.86%

Source: S&P Capital IQ. Standard template. Financial Sources.